J Rheum Dis.  2018 Jan;25(1):1-2. 10.4078/jrd.2018.25.1.1.

Comparison of Disease Activity Score-28 Based on Erythrocyte Sedimentation Rate and C-reactive Protein Level in Rheumatoid Arthritis

• Lee YH

• KMID: 2405014
• DOI: http://doi.org/10.4078/jrd.2018.25.1.1

Abstract

No abstract available.

MeSH Terms

Arthritis, Rheumatoid*
Blood Sedimentation*
C-Reactive Protein*
Erythrocytes*
C-Reactive Protein

Reference

1. van der Heijde DM, van't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990; 49:916–20.

2. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38:44–8.

3. Fransen J, van Riel PL. The disease activity score and the EULAR response criteria. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S93–9.

4. Talstad I, Scheie P, Dalen H, Röli J. Influence of plasma proteins on erythrocyte morphology and sedimentation. Scand J Haematol. 1983; 31:478–84.

5. van Leeuwen MA, van Rijswijk MH, van der Heijde DM, Te Meerman GJ, van Riel PL, Houtman PM, et al. The acutephase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol. 1993; 32(Suppl 3):9–13.

6. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010; 69:964–75.

7. Tamhane A, Redden DT, McGwin G Jr, Brown EE, Westfall AO, Reynolds RJ 4th, et al. Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis. J Rheumatol. 2013; 40:1812–22.

8. Castrejón I, Ortiz AM, García-Vicuña R, Lopez-Bote JP, Humbría A, Carmona L, et al. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol. 2008; 26:769–75.

9. Song GG, Lee YH. Comparison of disease activity score 28 using C-reactive protein and disease activity score 28 using erythrocyte sedimentation rate in assessing activity and treatment response in rheumatoid arthritis: a meta-analysis. J Rheum Dis. 2016; 23:241–9.

10. Fleischmann RM, van der Heijde D, Gardiner PV, Szumski A, Marshall L, Bananis E. DAS28-CRP and DAS28-ESR cutoffs for high disease activity in rheumatoid arthritis are not interchangeable. RMD Open. 2017; 3:e000382.

11. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis. 2007; 66:407–9.

12. Choi IA. Comparison of the disease activity score-28 based on the erythrocyte sedimentation rate and C-reactive protein in rheumatoid arthritis. J Rheum Dis. 2017; 24:287–92.